Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MTUM vs GSK✓SelectedUSD · GSKMTUM vs GSK performance historyLatest closeAs of-0.14%11/18
Stock and ETF performance explorer

MTUM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+499.5%
GSK return
+86.2%
Excess return
+413.3%
Maximum drawdown
-34.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-1.3%+1.2%+0.3%
7D-5.8%-3.1%-2.7%-4.9%
30D-11.8%-0.9%-10.9%-11.7%
3M-16.2%-4.2%-12.0%-15.5%
6M-11.1%-1.6%-9.5%-11.7%
YTD+4.6%+2.6%+2.0%+1.8%
1Y+8.5%+6.2%+2.3%+4.2%
3Y+78.1%+55.0%+23.1%+42.9%
5Y+46.4%+42.8%+3.5%+19.3%
10Y+288.7%+102.1%+186.5%+164.0%
All+499.5%+86.2%+413.3%+309.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling